How big is the Thailand Oral Antidiabetic Drug Market?

The Thailand Oral Antidiabetic Drug Market size is expected to reach USD 82 million in 2024 and grow at a CAGR of greater than 6% to reach USD 109 million by 2029. Read More

What is the current Thailand Oral Antidiabetic Drug Market size?

In 2024, the Thailand Oral Antidiabetic Drug Market size is expected to reach USD 82 million. Read More

Who are the key players in Thailand Oral Antidiabetic Drug Market?

Astrazeneca, Astellas, Janssen, Eli Lilly and Sanofi are the major companies operating in the Thailand Oral Antidiabetic Drug Market. Read More

What years does this Thailand Oral Antidiabetic Drug Market cover, and what was the market size in 2023?

In 2023, the Thailand Oral Antidiabetic Drug Market size was estimated at USD 77.08 million. The report covers the Thailand Oral Antidiabetic Drug Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Thailand Oral Antidiabetic Drug Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Thailand Oral Antidiabetic Drug Market Share

Statistics for the 2023 & 2024 Thailand Oral Antidiabetic Drug market share, created by Mordor Intelligence™ Industry Reports. Thailand Oral Antidiabetic Drug share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Thailand Oral Antidiabetic Drug Industry

The Thailand Oral Anti-diabetic Drug Market is consolidated, with a few major manufacturers like Eli Lilly, AstraZeneca, Sanofi, and Janssen Pharmaceuticals having a global market presence. In contrast, the remaining manufacturers are confined to the other local or regional markets. Companies are focusing on innovations in diabetes drugs.